After OVCA, the highest frequency of CNL affecting RBX1 was observed in breast cancer (BRCA), at 45.5%, while other gynecological tumors, such as uterine corpus endometrial carcinoma (UCEC), showed RBX1 CNL in only 17.05% of cases (Figure 7(c)). Here, RBX1 is linked to uterine corpus endometrial carcinoma.